A detailed history of Juncture Wealth Strategies, LLC transactions in Novartis Ag stock. As of the latest transaction made, Juncture Wealth Strategies, LLC holds 5,900 shares of NVS stock, worth $637,967. This represents 0.25% of its overall portfolio holdings.

Number of Shares
5,900
Previous 6,198 4.81%
Holding current value
$637,967
Previous $625,000 8.8%
% of portfolio
0.25%
Previous 0.29%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

SELL
$95.27 - $108.47 $28,390 - $32,324
-298 Reduced 4.81%
5,900 $570,000
Q4 2023

Jan 08, 2024

BUY
$92.27 - $101.54 $18,454 - $20,308
200 Added 3.33%
6,198 $625,000
Q3 2023

Oct 10, 2023

SELL
$94.73 - $105.13 $9,473 - $10,513
-100 Reduced 1.64%
5,998 $610,000
Q2 2023

Jul 11, 2023

SELL
$92.52 - $104.91 $9,437 - $10,700
-102 Reduced 1.65%
6,098 $615,000
Q1 2023

May 05, 2023

SELL
$80.03 - $92.81 $24,009 - $27,843
-300 Reduced 4.62%
6,200 $570,000
Q4 2022

Jan 18, 2023

SELL
$75.55 - $92.52 $7,555 - $9,252
-100 Reduced 1.52%
6,500 $0
Q3 2022

Oct 11, 2022

BUY
$74.61 - $87.26 $44,766 - $52,356
600 Added 10.0%
6,600 $502,000
Q2 2022

Jul 14, 2022

BUY
$80.52 - $93.75 $16,104 - $18,750
200 Added 3.45%
6,000 $507,000
Q1 2022

Jul 14, 2022

BUY
$80.11 - $90.62 $40,055 - $45,310
500 Added 9.43%
5,800 $509,000
Q3 2021

Oct 15, 2021

BUY
$81.78 - $95.14 $32,712 - $38,056
400 Added 8.16%
5,300 $433,000
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $25,572 - $28,245
-300 Reduced 5.77%
4,900 $452,000
Q4 2020

Jan 25, 2021

BUY
$78.07 - $94.43 $78,070 - $94,430
1,000 Added 23.81%
5,200 $491,000
Q3 2020

Oct 15, 2020

SELL
$82.14 - $91.0 $24,642 - $27,300
-300 Reduced 6.67%
4,200 $365,000
Q2 2020

Jul 28, 2020

BUY
$80.93 - $91.1 $56,651 - $63,769
700 Added 18.42%
4,500 $393,000
Q1 2020

Apr 21, 2020

SELL
$70.67 - $99.01 $120,139 - $168,317
-1,700 Reduced 30.91%
3,800 $313,000
Q4 2019

Feb 03, 2020

SELL
$84.35 - $95.37 $8,435 - $9,537
-100 Reduced 1.79%
5,500 $521,000
Q3 2019

Oct 10, 2019

BUY
$85.54 - $94.26 $25,662 - $28,278
300 Added 5.66%
5,600 $487,000
Q2 2019

Jul 16, 2019

SELL
$75.4 - $92.8 $7,540 - $9,280
-100 Reduced 1.85%
5,300 $484,000
Q1 2019

Apr 09, 2019

BUY
$75.32 - $86.15 $112,979 - $129,225
1,500 Added 38.46%
5,400 $519,000
Q4 2018

Jan 17, 2019

SELL
$73.66 - $82.02 $66,294 - $73,818
-900 Reduced 18.75%
3,900 $335,000
Q3 2018

Oct 03, 2018

SELL
$66.94 - $77.43 $6,694 - $7,743
-100 Reduced 2.04%
4,800 $414,000
Q2 2018

Jul 13, 2018

BUY
$64.91 - $73.36 $25,964 - $29,344
400 Added 8.89%
4,900 $370,000
Q1 2018

Apr 25, 2018

SELL
$70.39 - $84.15 $35,195 - $42,075
-500 Reduced 10.0%
4,500 $364,000
Q4 2017

Jan 22, 2018

BUY
$72.33 - $77.64 $115,728 - $124,224
1,600 Added 47.06%
5,000 $420,000
Q3 2017

Oct 18, 2017

BUY
$74.14 - $77.27 $252,076 - $262,718
3,400
3,400 $292,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Juncture Wealth Strategies, LLC Portfolio

Follow Juncture Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.